| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |